Previous attempted therapies for heart failure have shown improvements to heart function on the order of 5-10%. cBIN1 gene therapy improved function by 30%. "It's night and day," Shaw adds.

At the University of Utah, scientists used a new gene therapy that was shown to reverse the effects of heart failure in a large animal study. In the study, pigs with heart failure were found to ...

In an effort to increase protein levels in heart failure, the researchers turned to a harmless virus commonly used in gene therapy to deliver an extra copy of the cBIN1 to heart cells. The virus ...

Heart attacks are dangerous not just because of the initial event, but the long-term damage afterwards. Now scientists have ...

An experimental gene therapy successfully treated heart failure in pigs The therapy actually ... “We call this reverse remodeling,” Hong added in a university news release.

New Gene Therapy Reverses Heart Failure in Large Animal Model Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart ...

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

Bayer’s AskBio unit has reported the first clinical data for its congestive heart failure gene therapy ... the current standard of care does not reverse the trajectory of the disease to ultimate ...

A gene therapy for heart failure being developed by Bayer’s AskBio unit has been granted fast-track status by the FDA, shortly after it showed preliminary signs of efficacy in a phase 1 trial.

A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the amount of blood the heart can pump and dramatically ...